Schedule 13D ownership disclosure

PLX PHARMA INC. XXXBANKRUPTCY EFF: 10/02/23

Security class unavailable · CUSIP: 72942A107

Event date: 2018-12-20

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
16.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000905718-18-001016
Form type
SC 13D/A
Filer
PLx Pharma Inc.
CIK
CIK 1497504
Filed
Dec 31, 2018
Reporting period
Dec 20, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub